Recent research indicates alcohol is a major risk factor in cancer and other serious illnesse. New studies suggest that there ...
Researchers have identified a promising new strategy for treating alcohol use disorder (AUD). A novel study found that the dopamine-boosting drug tolcapone increases activity in the prefrontal cortex ...
A quantitative alcohol history should be recorded for all patients, because alcohol use contributes to many physical and mental disorders. A person-centered, nonjudgmental approach should be adopted.
Oxytocin has been proposed to play a role in the development and maintenance of alcohol use disorder (AUD) through its interactions with stress pathways. Empirical evidence that indicates altered ...
Once weekly semaglutide injections reduced alcohol consumption in patients with alcohol use disorder (AUD) and comorbid obesity. Results of the randomized controlled trial (RCT), the first, to the ...
No alcohol withdrawal symptoms despite episodic heavy drinking? That doesn't mean alcohol is not affecting your brain, ...
Alcohol use disorder is a major cause of disease and premature death worldwide. For people with chronic liver disease (CLD), there is no safe level of alcohol consumption. Yet many patients with this ...
The off-label use of baclofen in the treatment of alcohol use disorders (AUD) increased significantly between 2007 and 2013 in France. In March 2014, a temporary recommendation for use (TRU) was ...
Randomized control trials that are shorter than 12 weeks show similar results to longer trials when assessing a new ...
Some psychedelics, psychoactive substances that alter people's mood, perceptions and mental processes, were recently found to be promising alternative treatments for some mental health disorders. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results